Molecular studies on the impact of microbiome on anticancer drug resistance
Ke Zhou, Ping Lu, Hongli Xu, Ling Wang, Xinjun Liang · 2026
Read Molecular studies on the impact of microbiome on anticancer drug resistance by Ke Zhou, Ping Lu, Hongli Xu, Ling Wang, Xinjun Liang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13310915.txt.
Description
Ke Zhou and co-authors review how gut germs drive cancer drug resistance in a 2026 paper. Cancer care often fails when tumors stop responding to chemo, immune, or targeted drugs. Gut germs can change that outcome by breaking down drugs, tuning immunity, altering host drug handling, and reshaping the tumor setting.
Some germ types switch off chemo drugs directly, while germ products rewire survival paths in tumor cells. Diet change, helpful germs, stool transplant, and smart drug carriers are under study as counters. Joining germ data with tumor data may let doctors predict resistance and tailor care. Human proof remains early.
Catalog record
| CREATOR | Ke Zhou, Ping Lu, Hongli Xu, Ling Wang, Xinjun Liang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36920 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |